Drs. Kariisa and Roehler will provide an overview of CDC’s Enhanced State Opioid Overdose Surveillance (ESOOS) program. We will highlight the three key strategies CDC is employing to improve opioid-related...
Message from an amalgamation of research findings for the American Psychological Association is that conveying genuineness and authenticity - at least during therapy, being and giving of yourself as an integrated character - is one way therapists underpin an effective therapeutic relationship. But what if a therapy’s mandates demand a less than genuine response?
This webinar will provide an overview of the U.S. opioid crisis and technical assistance models. Participants will gain a complete understanding of technical assistance and how it can assist providers in addressing addiction-related needs...
The greatest challenge using motivational interviewing (MI) may be finding the “true” ambivalence it’s supposed to address. This webinar is designed to assist clinicians who want to use MI effectively with clients with co-occurring...
El objetivo del Programa es capacitar a profesionales del ámbito sociosanitario en la adquisición de conocimientos y habilidades para mejorar la prevención, detección y atención a las mujeres en situación de drogodependencia desde la perspectiva de género. Las transformaciones sociales traen...
While several pharmacotherapies have been developed for substance use disorders (SUD) in adults, relatively few have been studied in adolescents, and complex design and execution issues must be addressed to optimize the potential impact of current and future research in this important area. This one...
In the CTN, investigators and research staff engage in the conduct of studies and treatment for patients dealing with substance use and mental health disorders. There are a number of interventions and approaches used for relapse prevention and recovery, including coaching and counseling for...
Motivational Interviewing (MI) is an empirically supported treatment for substance use disorders and a variety of other problematic behaviors. Over three decades of research have established the clinical effectiveness of MI and some of its mechanisms of action. This webinar, presented by Steve...
This 3-hour refresher course, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, to help assure appropriate administration of the Addiction Severity Index (ASI), a standardized screening and assessment instruments...
Alcohol consumption in pregnancy has the potential to cause significant fetal damage. It is estimated that approximately 3.2% of babies born in the UK are affected by fetal alcohol spectrum disorder, though the guidance says currently few children are identified or receive support.
The Scottish Intercollegiate Guidelines Network has developed new guidelines improve understanding, identification and care for those affected by prenatal alcohol exposure.
The guideline includes information to support clinicians identifying children who have been affected by prenatal alcohol exposure and who are...
TheIOTOD conference is an annual, CME-accredited, two-day event developed in partnership with internationally-renowned leading opioid dependence experts.
The latest innovations, controversies and emerging challenges are covered, ensuring...
Application Due Date: Friday, March 29, 2019 SAMHSA is accepting applications for National Center of Excellence for Integrated Health Solutions (CIHS) grants. The purpose of this program is to advance the implementation of high quality, evidence-based treatment for individuals with co-occurring...
Application Due Date: Monday, March 25, 2019 SAMHSA is accepting applications for Targeted Capacity Expansion: Special Projects (TCE – Special Projects) grants. The purpose of this program is to develop and implement targeted strategies for substance use disorder treatment provision to address a...
The Cochrane Drugs and Alcohol Group specialises in reviews that assess, among other things, ways to reduce hazardous or harmful drinking of alcohol.
One of these reviews looks at the evidence on practitioner-delivered brief interventions and we asked one of the authors, Fiona Beyer from Newcastle University in the UK to tell us about the findings from the update in February 2018.
Ashford, Robert D., Austin M. Brown, and Brenda Curtis. "Systemic barriers in substance use disorder treatment: A prospective qualitative study of professionals in the field." Drug and alcohol dependence (2018).
The US is experiencing a public health crisis. In the US in 2016 alone, there were over 63,000 drug poisoning deaths. Despite these concerning figures, it is estimated that fewer than 20% (3.8 million) receive treatment and for those who do receive support relapse rates are high.
A recent study, published in the Journal of Drug and Alcohol Dependence, interviewed practitioners to get their perspectives on the barriers people face trying to access treatment and the challenges they face during their time receiving care.
182 substance use treatment professionals participated in the study.
Tobacco smoking is a chronic disease affecting one fifth of our population. Most smokers, however, are not conscious nor seek treatment for their problem. Some patients are able to reach abstinence by themselves but the majority need some kind of medical-psychological therapy. The best therapy to...
This website offers resources developed from a two-year research programme on end of life care for people with alcohol and other drug problems. The research programme was the first of its kind to explore current practice and service experience from a range of perspectives.
The findings have been used to develop information and resources on how best to support people with substance use problems, or how substance use services can support people with serious and life-limiting conditions.